Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Sensory and Autonomic Neuropathy Type I”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Testing effectiveness (Phase 2)Study completedNCT01733407
What this trial is testing

L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1

Who this might be right for
Hereditary Sensory and Autonomic Neuropathy Type I
Massachusetts General Hospital 18
Large-scale testing (Phase 3)UnknownNCT02055079
What this trial is testing

Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Polycystic Kidney, Type 1 Autosomal Dominant DiseasePolycystic Kidney, Type 2 Autosomal Dominant Disease
Medical University of Vienna 68
Early research (Phase 1)Ended earlyNCT04800822
What this trial is testing

PF-07284892 in Participants With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Pfizer 53
Testing effectiveness (Phase 2)Looking for participantsNCT04657068
What this trial is testing

ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced CancerMetastatic CancerOvarian Cancer+6 more
Artios Pharma Ltd 442
Early research (Phase 1)Study completedNCT00726583
What this trial is testing

Phase I Trial of Oral PX-866

Who this might be right for
Advanced Solid Tumors
Cascadian Therapeutics Inc. 90
Testing effectiveness (Phase 2)UnknownNCT06113055
What this trial is testing

Hereditary Sensory Neuropathy Serine Trial

Who this might be right for
Hereditary Sensory Neuropathy Type I
University College, London 50
Testing effectiveness (Phase 2)Study completedNCT00411619
What this trial is testing

Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex

Who this might be right for
Tuberous SclerosisSubependymal Giant Cell Astrocytoma
Children's Hospital Medical Center, Cincinnati 28
Testing effectiveness (Phase 2)Study completedNCT00457964
What this trial is testing

RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosis
Children's Hospital Medical Center, Cincinnati 36
Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Early research (Phase 1)Looking for participantsNCT03423628
What this trial is testing

Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Who this might be right for
Recurrent Glioblastoma MultiformePrimary Glioblastoma MultiformeBrain Neoplasms, Malignant+1 more
AstraZeneca 180
Not applicableStudy completedNCT07263256
What this trial is testing

Median Nerve Decompression for Complex Regional Pain Syndrome: A Clinical Study

Who this might be right for
Complex Regional Pain Syndrome I (CRPS I)Nerve Entrapment Syndrome
Jitka Fricova 74
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Testing effectiveness (Phase 2)WithdrawnNCT01960023
What this trial is testing

Safety and Efficacy Study of Neratinib and Cetuximab to Treat Patients With Quadruple Wild-Type Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
NSABP Foundation Inc